JPRN-UMIN000037240招募中未知
Evaluation of the efficacy of romosozumab for glucocorticoid-induced osteoporosis in long-term glucocorticoid administration patients - Evaluation of the efficacy of romosozumab for glucocorticoid-induced osteoporosis in long-term glucocorticoid administration patients
Toho University School of Medicine Division of Rheumatology, Department of Internal Medicine0 个研究点目标入组 200 人开始时间: 2019年7月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who have received romosozumab 2. Patients with contraindication for romosozumab or denosumab or bisphosphonate 3. Patients with severe renal dysfunction (eGFR < 30mL/min/1.73m2) 4. Patients who is currently pregnant, breastfeeding or willing to get pregnant 5. Patients who do not give consent to the study 6. Patients who are judged to be inappropriate by the physician
研究者
相似试验
招募中
不适用
Evaluation of the efficacy of romosozumab for glucocorticoid-induced osteoporosis in initial glucocorticoid administration patientsglucocorticoid-induced osteoporosisJPRN-UMIN000037239Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine90
招募中
不适用
Evaluation of efficacy and safety of romosozumab administration group and ibandronate sodium hydrate administration group for osteoporosis patients after denosumab treatmentosteoporosisJPRN-UMIN000037394Shinshu University School of Medicine Dept. of Orthopaedic Surgery60
已完成
不适用
Evaluation of the efficacy of romosozumab for hemodialysis patients with hemodialysisosteoporosisJPRN-UMIN000039889Showa University18
招募中
1 期
The OPTIMIST studyosteoporosisCTIS2023-505940-20-00Region Midtjylland270
尚未招募
不适用
Evaluation of the efficacy and safety of romosozumab alone and romosozumab + denosumab combination for patients with osteoporosis treated with 2-year denosumabosteoporosisJPRN-UMIN000037123Shinshu University School of Medicine Dept. of Orthopaedic Surgery60